BioXcel Therapeutics Announces Pricing of $7.0 Million Public …

NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, …

CouponFollow Extension

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

bioxceltherapeutics.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

21 hours ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing …

yahoo.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

1 day ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company&CloseCurlyDoubleQuote;) (Nasdaq: BTAI), a biopharmaceutical company …

stockhouse.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

21 hours ago · BioXcel Therapeutics announces pricing of public offering at $0.48 per share, grossing $7 million. ... at a combined public offering price of $0.48 per share and …

seekingalpha.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

BioXcel Therapeutics ... at a combined public offering price of $0.48 per share and accompanying warrant. ... Gross proceeds to the company from the offering are expected to be about $7 million.

msn.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

21 hours ago · BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative ... at a combined …

einnews.com

$7
OFF

BioXcel Therapeutics (BTAI) Announces Pricing Of $7.0 Million …

6 days from now

21 hours ago · BioXcel Therapeutics, Inc. ... at a combined public offering price of $0.48 per share and accompanying warrant (or $0.479 per share underlying each pre-funded warrant and …

streetinsider.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

21 hours ago · BioXcel Therapeutics (BTAI) has announced the pricing of a $7.0 million public offering, consisting of 5,600,000 shares of common stock and warrants to purchase up to …

stocktitan.net

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million

6 days from now

21 hours ago · Gross proceeds to the Company from the offering are expected to be approximately $7.0 million, before deducting underwriting discounts and commissions and …

globenewswire.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the â Companyâ ) ( BTAI), a biopharmaceutical company utilizing artificial i 🚀 Enjoy a 7-Day Free …

gurufocus.com

$7
OFF

BioXcel Therapeutics Prices Of $7 Million Public Offering

6 days from now

1 day ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to …

citybiz.co

$0.00
OFF

BioXcel Therapeutics Prices 5.6M Shares At 48c In Public Offering

6 days from now

1 day ago · BioXcel Therapeutics (BTAI) announced the pricing of an underwritten public offering of 5,600,000 shares of its common stock, par value $0.001 per share and accompanying …

businessinsider.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

21 hours ago · BioXcel Therapeutics Announces Pricing of $7.0 Million Public Offering. ... 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc ... which equals the public offering price …

streetinsider.com

$7
OFF

BioXcel Therapeutics Announces $7M Public Offering

6 days from now

19 hours ago · BioXcel Therapeutics Inc., ... The company said its underwritten public offering of 5.6 million shares of its common stock, with a par value of $0.001 per share, and …

hartfordbusiness.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

21 hours ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the "Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing …

manilatimes.net

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

BTAI BioXcel Therapeutics Inc BioXcel Therapeutics Announces Pricing of $7.0 Million Public Offering. NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, …

advfn.com

FAQs about BioXcel Therapeutics Announces Pricing of $7.0 Million Public … Coupon?

What is BioXcel Therapeutics?

BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company that utilizes artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. ...

How much did bioxcel Therapeutics raise in an IPO?

BioXcel Therapeutics (BTAI) raised $60 million in their IPO on Thursday, March 8th 2018. The company issued 5,000,000 shares at a price of $11.00-$13.00 per share. $60 million was raised in the IPO. ...

What was the closing price of bioxcel Therapeutics Inc registered SHS?

On Thursday 08/22/2024 the closing price of the BioXcel Therapeutics Inc Registered Shs share was $0.65 on BTT. Compared to the opening price on Thursday 08/22/2024 on BTT of $0.67, this is a drop of 2.47%. BioXcel Therapeutics Inc Registered Shs's market capitalization is $27.14 M by 40.74 M shares outstanding. ...

Will BioXcel Therapeutics lose value?

If things turn out that way, BioXcel Therapeutics will lose a substantial percentage of its value. We will know soon enough whether this is the case and if the company's ongoing launch of Igalmi in its current indication could come short of expectations. ...

Is bioxcel Therapeutics a good stock to buy?

According to analysts, BioXcel Therapeutics has a consensus rating of Hold. The company's average rating score is 2.43, based on 3 buy ratings, 4 hold ratings, and no sell ratings. BioXcel Therapeutics has only been the subject of 3 research reports in the past 90 days. ...

What is the debt level of BioXcel Therapeutics?

A higher level of debt in BioXcel Therapeutics' case amounts to 73% of its equity. Generally, the rule of thumb is debt shouldn’t exceed 40% of your equity, which increases the risk around investing in a loss-making company. ...